Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting.

Journal of inherited metabolic disease - 1 Oct 2010

Lindner Martin, Hoffmann Georg F, Matern Dietrich

Abstract excerpt

Experience with new-born screening (NBS) for disorders of fatty-acid oxidation (FAOD) is now becoming available from an increasing number of programs worldwide. The spectrum of FAOD differs widely between ethnic groups. Incidence calculations from reports from Australia, Germany, and the USA of a total of 5,256,999 newborns give a combined incidence of all FAOD of approximately 1:9,300. However, it appears to be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Energy Metabolism
Share to Fatty Acids
Share to Lipid Metabolism, Inborn Errors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mitochondrial Diseases

Share to Neonatal Screening

Share to Oxidation-Reduction

Share to Practice Guidelines as Topic

Share to Predictive Value of Tests

Source

Identifiers

PMID: 20373143
DOI: 10.1007/s10545-010-9076-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting.PMID 20373143Read ↗

Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disordersSemantic proximity Read ↗

Newborn screening for fatty acid oxidation disorders: epidemiological and genetic findings in Southeastern China.Semantic proximity Read ↗

Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.Semantic proximity Read ↗

Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: regional experience and high incidence of carnitine deficiency.Semantic proximity Read ↗

Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective.Semantic proximity Read ↗

Medium-chain acyl-CoA deficiency: outlines from newborn screening, in silico predictions, and molecular studies.Semantic proximity Read ↗

Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.Semantic proximity Read ↗

Clinical, Biochemical and Molecular Characterisation of Newborns With Fatty Acid β-Oxidation Disorders: Novel Variants in the ACADM , ACADVL and SLC22A5 Genes.Semantic proximity Read ↗

Fatty acid oxidation disorders: outcome and long-term prognosis.Semantic proximity Read ↗

Dissection of biochemical borderline phenotypes in carriers and genetic variants of medium-chain acyl-CoA dehyrogenase deficiency: implications for newborn screening [corrected].Semantic proximity Read ↗

Clinical and biochemical features of fatty acid oxidation disorders.Semantic proximity Read ↗

Clinical, biochemical, and molecular spectrum of short/branched-chain acyl-CoA dehydrogenase deficiency: two new cases and review of literatureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.